JW (CAYMAN) THERAPEUTICS CO. LTD financial statements, including revenue, expenses, and profit
The total revenue of 2126 for the last semiannual is 77.46 M HKD, and it's 17.66% lower compared to the previous semiannual. The net income of H2 24 is -380.07 M HKD.